Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody.
D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D003384:Coxsackievirus Infections / Q000097:blood / Q000188:drug therapy / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004770:Enterovirus / Q000254:growth & development / Q000276:immunology* / Q000302:isolation & purification; D006321:Heart / Q000382:microbiology; D007106:Immune Sera / Q000008:administration & dosage; D007112:Immunity, Maternally-Acquired; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007372:Interferons / Q000097:blood; D051379:Mice; D008808:Mice, Inbred CBA; D009206:Myocardium / Q000473:pathology; D010179:Pancreas / Q000382:microbiology / Q000473:pathology; D013934:Thymectomy; D013997:Time Factors
D000914:Antibodies, Viral; D007106:Immune Sera; D003520:Cyclophosphamide; D007372:Interferons